Akums Drugs and Pharmaceuticals Limited IPO 2024: An Insightful Overview for Investors
Overview
Akums Drugs and Pharmaceuticals Limited, a leading pharmaceutical contract development and manufacturing organization (CDMO), is set to launch its initial public offering (IPO) on July 30, 2024. The company offers end-to-end solutions for product development, manufacturing, research and development (R&D) of formulations, regulatory dossier preparation, and submission, along with other testing services.
IPO Details
| Details | Information |
|---|---|
| Face Value | ₹2 per share |
| Issue Price (Lower) | ₹649.00 per share |
| Issue Price (Upper) | ₹679.00 per share |
| Issue Price (Final) | ₹679.00 per share |
| Fresh Issue Size | up to ₹680.00 Cr |
| OFS Issue Size | up to ₹1,176.74 Cr |
| Issue Size Total | up to ₹1,856.74 Cr |
| Lot Size | 22 shares |
| Minimum Lot Size | 1 lot |
Reservation Details
| Category | Shares Reserved |
|---|---|
| QIB | 75% |
| NII | 15% |
| RII | 10% |
| Employee | – |
| Total | 100% |
Key Dates
| Event | Date |
|---|---|
| Issue Open | Jul 30, 2024 |
| Issue Close | Aug 01, 2024 |
| Basis Of Allotment (Tentative) | Aug 02, 2024 |
| Initiation of Refunds (Tentative) | Aug 05, 2024 |
| Credit of Share (Tentative) | Aug 05, 2024 |
| Listing date (Tentative) | Aug 06, 2024 |
Financial Overview
| Particulars | Year Ending on March 31, 2024 | Year ending on March 31, 2023 | Year ending on March 31, 2022 |
|---|---|---|---|
| Equity Share Capital | 286.13 | 286.13 | 143.07 |
| Other equity | 6,808.85 | 6,885.76 | 6,076.69 |
| Net Worth | 7,204.86 | 7,233.74 | 6,251.71 |
| Total Borrowings | 782.97 | 1,154.96 | 1,019.36 |
IPO Prospectus
- IPO DRHP: Click Here
- IPO RHP: Click Here
Missed Something?
So Hey Traders! Let’s get back to the IPO TABLES.
